{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • Internal Series
  • On-Demand Activities
  • CE Planning Process
  • Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2024 Research Updates in Lymphoma


2024 Research Updates in Lymphoma Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Exhibitor Registration
Add to Calendar 2024 Research Updates in Lymphoma 9/28/2024 8:30:00 AM 9/29/2024 2:00:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/course/courseoverview?EID=25463 Description: To register for 2025, click here: https://cedars.cloud-cme.com/lymphomacmeThis conference will provide a chance for Southern California lymphoma specialists and national experts to gather and discuss updates and advancements in lymphoma treatment and research. The clinical updates sessions will highlight newly approved therapies and those in the pipeline. Case based, "How I Treat" sessions will addres... Cedars-Sinai Advanced Health Science Pavilion Educational Center false MM/DD/YYYY


Date & Location
Saturday, September 28, 2024, 8:30 AM - Sunday, September 29, 2024, 2:00 PM PST, Cedars-Sinai Advanced Health Science Pavilion Educational Center, Los Angeles, CA

Target Audience
Specialties - Hematology, Imaging, Internal Medicine, Oncology, Pathology & Laboratory Medicine, Radiation Oncology, Radiology, Surgery
Professions - Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Researcher (non-physician), Researcher (physician)

Overview


To register for 2025, click here:
https://cedars.cloud-cme.com/lymphomacme



This conference will provide a chance for Southern California lymphoma specialists and national experts to gather and discuss updates and advancements in lymphoma treatment and research. The clinical updates sessions will highlight newly approved therapies and those in the pipeline. Case based, "How I Treat" sessions will address questions of sequencing therapies and patients selection. The scientific sessions will present high impact basic science with high translational relevance, such as new biomarkers, therapeutic targets and novel cellular therapies.


Objectives
  1. Recognize the utility of molecular testing in the classification and treatment of lymphoma
  2. Identify current evidence based treatments for Hodgkin lymphoma, diffuse large B-cell lymphoma, and peripheral T-cell lymphoma
  3. Describe new treatments under development including bi-specific antibodies and CART therapies

Registration

In-Person Fees
In-Person: Healthcare Professional Fee - $0.00
In-Person: Industry Attendee (No Exhibit Booth) - $450.00

Virtual Fees
Virtual: Healthcare Professional Fee - $0.00
Virtual: Industry Attendee (No Exhibit Booth) - $450.00


Health and Safety Protocol
Before registering for this event, please read our Health and Safety Protocol for current requirements pertaining to attending in-person events. 

 

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548. 



Accreditation

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION OF CREDIT:
AMA for Physicians: Cedars-Sinai designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA Attendance for Non-Physicians: Attendance credit will be provided to other health care professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.


Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (10.00 hours), Non-Physician AMA Attendance (10.00 hours)


Keywords: LIVEAMA



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Justin Darrah, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Akil Merchant, MD
Cedars-Sinai
Course Director, Faculty
Advisor-Novartis AG|Advisor-Pfizer, Inc.|Advisor-Morphosys|Consultant-Genmab|Consultant-Abbvie
Ash A Alizadeh, MD, PhD
Stanford Medicine
Faculty
Other: Co-founder, Advisor-Foresight Diagnostics|Other: Co-founder, Advisor-CiberMed |Royalties or Patent Beneficiary-Cargo Therapeutics (Relationship has ended)|Advisor-Adaptive Biotechnologies (Relationship has ended)|Other: Food/beverage ($15.51)-Pharmacyclics, Inc. (Relationship has ended)
Celeste C Eno, PhD, FACMG
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Javeed Iqbal, PhD
University of Nebraska Medical Center
Faculty
Nothing to disclose
Sumire Kitahara, MD
Faculty
Nothing to disclose
Justin Kline, MD
University of Chicago
Faculty
Advisor-Abbvie|Advisor-Genmab (Relationship has ended)|Advisor-Seagen (Relationship has ended)|Consultant-Bristol-Myers Squibb|Consultant (Relationship has ended)
Joseph C. Lownik, MD
Cedars-Sinai
Faculty
Nothing to disclose
Jun Park, PhD
UCLA
Faculty
Nothing to disclose
Erin M. Parry, MD, PhD
Dana-Farber Cancer Institute
Faculty
Nothing to disclose
Andrea Radtke, PhD
National Institutes of Health
Faculty
Nothing to disclose
Andrew Roth, PhD
British Columbia Cancer Agency
Canada
Faculty
Nothing to disclose
Faculty Photos
Joshua Sasine, MD, PhD
Cedars-Sinai
Faculty
Advisor-Kite Pharma (Relationship has ended)|Advisor-Genmab (Relationship has ended)|Advisor-Autolus (Relationship has ended)
Matt Thomson
Heritage Medical Research Institute. Caltech
Faculty
Nothing to disclose
Lisa Wagar, PhD
UCI School of Medicine
Faculty
PrincipalNamedInvestigator-F. Hoffmann La Roche Ltd.|PrincipalNamedInvestigator-Bristol-Myers Squibb
Alexander Xu, PhD
University of Maryland
Faculty
Nothing to disclose
Ken H Young, MD, PhD
Duke University Medical Center | Duke Cancer Institute
Faculty
Nothing to disclose

Saturday, September 28, 2024
Day 1 Recording
8:30AM - 4:00PM
Disclosure and Accredidation Information
8:30AM - 8:40AM
Registration Check In and Exhibits
8:30AM - 9:00AM
Welcome and Introduction
9:00AM - 9:10AM
 
Clinical Updates

Updates in B-cell Lymphoma
9:10AM - 9:40AM
Justin Darrah, MD
Novel treatments for Hodgkin and T cell lymphoma
9:40AM - 10:05AM
Akil Merchant, MD
Break
10:05AM - 10:30AM
What’s new in cellular therapy for lymphoma: Auto vs Allo, targets beyond CD19
10:30AM - 11:00AM
Joshua Sasine, MD, PhD
Pathology Updates: What’s new with WHO classification
11:00AM - 11:20AM
Sumire Kitahara, MD
Role of genetic classification in lymphoma
11:20AM - 11:40AM
Celeste C Eno, PhD, FACMG
Lunch, Conversation and Networking
11:40AM - 12:15PM
KEYNOTE: Cell Free DNA in Lymphoma
12:15PM - 1:00PM
Ash A Alizadeh, MD, PhD
 
Scientific Session: TME in Lymphoma

SUMOylation regulates T cell exhaustion in lymphoma
1:00PM - 1:20PM
Joseph C. Lownik, MD
Ligand Receptor Cross talk in Hodgkin lymphoma
1:20PM - 1:40PM
Alexander Xu, PhD
Genetics of Mantle Cell Lymphoma
1:40PM - 2:00PM
Javeed Iqbal, PhD
Single Cell Analysis of the TME in PTCL
2:00PM - 2:20PM
Akil Merchant, MD
Break
2:20PM - 2:50PM
Integrative genomic analysis identifies DLBCL immune environments associated with bispecific antibody response
2:50PM - 3:10PM
Justin Kline, MD
Unexpected Metabolic Reprogramming in CAR-T Cells
3:10PM - 3:40PM
Jun Park, PhD
Tumor-Infiltrating Normal B Lymphocytes and Immune cells Impact Outcomes in Primary and Transformed Diffuse Large B-Cell Lymphoma
3:40PM - 4:00PM
Ken H Young, MD, PhD
Social Hour
4:00PM - 5:30PM
Sunday, September 29, 2024
Day 2 Recording
8:30AM - 2:00PM
Registration Check In and Exhibits
8:30AM - 8:50AM
 
Workshop on the Biology of Transformation

Welcome and introduction
8:50AM - 9:00AM
Genetic and Molecular Mechanisms in Transformation of NHL
9:00AM - 9:30AM
Ash A Alizadeh, MD, PhD
Transformation in CLL
9:30AM - 10:00AM
Erin M. Parry, MD, PhD
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma
10:00AM - 10:30AM
Andrew Roth, PhD
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
10:30AM - 11:00AM
Andrea Radtke, PhD
Break and Exhibits
11:00AM - 11:15AM
Using organoids to model follicular Lymphoma
11:15AM - 11:45AM
Lisa Wagar, PhD
Mathematical modeling to generate testable hypotheses from spatial profiling data
11:45AM - 12:15PM
Matt Thomson
Lunch time Round Table: Major Knowledge Gaps and Research Opportunities in Transformed Lymphoma
12:30PM - 2:00PM

 

Dear Prospective Exhibitors,

Cedars-Sinai wishes to invite you to register as an exhibitor for 2024 Research Updates in Lymphoma scheduled for September 28-29, 2024 at the Cedars-Sinai Medical Center, Los Angeles, CA.

This conference will provide a chance for Southern California lymphoma specialists and national experts to gather and discuss updates and advancements in lymphoma treatment and research. The clinical updates sessions will highlight newly approved therapies and those in the pipeline. Case based, "How I Treat" sessions will address questions of sequencing therapies and patients selection. The scientific sessions will present high impact basic science with high translational relevance, such as new biomarkers, therapeutic targets and novel cellular therapies.

For more information visit: https://cedars.cloud-cme.com/lymphomacme

Exhibit Packages Available: $3500.00

Exhibit Package Includes:
One 6ft Table Top, includes 2 chairs
Number of Exhibitor Badges: 2

To secure your spot as an Exhibitor, we require completion of the Exhibit Interest Form, which includes being in full compliance with Cedars-Sinai Exhibit Guidelines and ACCME standards and policies. Please find the form attached to this email and send the completed form to [email protected].

Upon receipt of your form, we will process your registration and send you a receipt to collect your payment.  

Our non-profit tax I.D. number is: 95-1644600. A copy of our W9 and ACH Payment info can be found here: https://cedars.box.com/s/9b1zrvrnz28ol1oq0q46uexns09qir6e

Should you have any question or require additional information, please do not hesitate to [email protected]


Best regards,

Cedars-Sinai CME

Contact Us:
Office of CME
Cedars-Sinai
Los Angeles, CA
Email: [email protected]

  Exhibitor Invitation



CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization.